Penn’s Neuroscience & Society Lecture Series Presents "Cognitive Enhancing Drugs: Neuroscience and Society”

facebook twitter google print email
Media Contact:Jordan Reese | jreese@upenn.edu | 215-573-6604September 25, 2009

WHAT:

Barbara Sahakian, a world-renowned cognitive researcher and Penn Distinguished International Scholar, will present "Cognitive Enhancing Drugs: Neuroscience and Society," the first public talk in the Neuroscience & Society Lecture Series at the University of Pennsylvania.

WHO:

Sahakian, a professor at the University of Cambridge, is a leading expert on the effects of cognitive enhancing drugs on normal, healthy individuals, young and old. Her research is aimed at understanding the neural basis of cognitive, emotional and behavioral dysfunction in order to develop more effective pharmacological and psychological treatments. Recently, results from studies of ecstasy use and cognitive enhancement using methylphenidate, modafinil and atomoxetine have led to her interest in pharmacogenomics and neuroethics.

RSVPs can be sent to info@neuroethics.upenn.edu.

WHERE:

College Hall, Room 200, between 34th and 36th streets on Locust Walk, campus of the University of Pennsylvania

WHEN:

Thursday, Oct. 8, 2009, 4-5:30 p.m.

###

Multimedia